Name: Edith Bougouma

Country: Mali

Affiliation:

Centre National de Recherche et de Formation sur le Paludisme (CNRFP), Molecular biology.

Email: Send an Email


Address:

Centre National de Recherche et de Formation sur le Paludisme (CNRFP), Molecular biology.

Biography:

  • Edith Bougouma currently works at the Molecular biology, Centre National de Recherche et de Formation sur le Paludisme (CNRFP). 
  • Edith does research in Genetics, Human Biology and Molecular Biology. 
  • Their most recent publication is 'Safety of single low-dose primaquine in glucose-6-phosphate dehydrogenase deficient falciparum-infected African males: Two open-label, randomized, safety trials.'

Publications:

  1. Resistance to malaria through structural variation of red blood cell invasion receptors.
  2. Characterisation of the opposing effects of G6PD deficiency on cerebral malaria and severe malarial anaemia.
  3. Single low dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission after artemether-lumefantrine in children with asymptomatic infection: a randomised, double-blind, placebo-controlled trial.
  4. A phase 2b randomized, controlled trial of the efficacy of the GMZ2 malaria vaccine in African children..
  5. A novel locus of resistance to severe malaria in a region of ancient balancing selection.
  6. Genetic determinants of anti-malarial acquired immunity in a large multi-centre study.
  7. Novel Insights Into the Protective Role of Hemoglobin S and C Against Plasmodium falciparum Parasitemia.
  8. Efficacy and Safety of the Mosquitocidal Drug Ivermectin to Prevent Malaria Transmission After Treatment: A Double-Blind, Randomized, Clinical Trial.
  9. Reappraisal of known malaria resistance loci in a large multicenter study.
  10. A Phase 1b Randomized, Controlled, Double-Blinded Dosage-Escalation Trial to Evaluate the Safety, Reactogenicity and Immunogenicity of an Adenovirus Type 35 Based Circumsporozoite Malaria Vaccine in Burkinabe Healthy Adults 18 to 45 Years of Age.